ADHD
The FDA has broadened the indications for methylphenidate (Concerta) extended-release tablets in doses of 18 mg to 72 mg/day to include adults with attention-deficit hyperactivity disorder (ADHD).
Xolair to Get Black Box Warning The FDA requested that Genentech, Inc.